FDA Inspection
Catalent Maryland, Inc.Catalent Maryland, Inc. – FDA Inspection, Apr 9, 2025
Record Details
This FDA Inspection record concerns Catalent Maryland, Inc., with an inspection on April 9, 2025, issued by the Baltimore District Office, covering biologics.
View Company Profile
ID · 6a5adb56-4aae-4fb8-a5f2-0be2f8c58d24
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256114
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Catalent Maryland, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 24, 2023 | Not classified | Baltimore District Office | |
| November 4, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Catalent Maryland, Inc.
- FDA Inspection 1206063 - 2023-02-24
- FDA Inspection 1112131 - 2019-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.